Report error Found 603 of ic50 data for polymerid = 1571
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.0400nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.0500nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.0500nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.120nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.160nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.180nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.240nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.240nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.270nMAssay Description:Inhibition of human His-tagged PDE3B catalytic domain expressed in Escherichia coli BL21(DE3) pLysS cellsMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.270nMAssay Description:Inhibition of human His-tagged PDE3B catalytic domain expressed in Escherichia coli BL21(DE3) pLysS cellsMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.270nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.410nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.430nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.440nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.470nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.480nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 0.560nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 1.10nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 1.40nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 1.70nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 1.90nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 2.10nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 2.20nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 2.5nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 2.70nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 4nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 5nMAssay Description:Inhibition of human full length PDE3B expressed in Sf9 cells measured after 60 mins by [3H]-cAMP Scintillation proximity assayMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 5nMAssay Description:Inhibition of human full length PDE3B expressed in Sf9 cells measured after 60 mins by [3H]-cAMP Scintillation proximity assayMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 5nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 5.40nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 5.70nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 6.5nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 7nMAssay Description:Inhibition of human full length PDE3B expressed in Sf9 cells measured after 60 mins by [3H]-cAMP Scintillation proximity assayMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 7nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 8nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 9nMAssay Description:Inhibition of human full length PDE3B expressed in Sf9 cells measured after 60 mins by [3H]-cAMP Scintillation proximity assayMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 9nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 9nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 9.10nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 9.80nMAssay Description:Experimental objective: to determine the AMP/GMP expression based on fluorescence polarization, i.e., to trace binding of AMP/GMP to antibody so as t...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 10nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 10nMAssay Description:Inhibition of human recombinant PDE3BMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 13nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 14nMAssay Description:Inhibition of human recombinant PDE3BMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 15nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 16nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 16nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 16nMAssay Description:Inhibition of human recombinant PDE3BMore data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 17nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3B(Human)
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
US Patent
Affinity DataIC50: 17nMAssay Description:The commercially available 3H-cAMP Scintillation Proximity Assay (SPA, Perkin Elmer) system was used for enzyme inhibition studies. For the determina...More data for this Ligand-Target Pair
